Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas. - Wikidata - wikimedia - TriplyDB

Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.

Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.

http://www.wikidata.org/entity/Q37562093

about

Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma.DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes.Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.Early growth response-1 in the pathogenesis of cardiovascular disease.DNAzyme-based therapeutics for cancer treatment.Delivery of therapeutic RNA-cleaving oligodeoxyribonucleotides (deoxyribozymes): from cell culture studies to clinical trials.Positive regulation of TAZ expression by EBV-LMP1 contributes to cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma.Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers.Viral Oncology: Molecular Biology and Pathogenesis.(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.EBV based cancer prevention and therapy in nasopharyngeal carcinoma.

P2860

Q28077209-443DCE80-0573-4C48-ADBB-1D446B4C5329 Q34619214-0234B288-0464-44E2-9682-A0C12A032DBD Q35742407-20CF5A74-58CD-478E-BB2E-D2AAEAFA3F88 Q38249887-9AB70A46-B3F7-40E7-BDA7-616E67002A24 Q38378692-93E955F1-3AAC-410D-A8ED-0D7FBF133BCB Q38568602-0A0EB33B-F87C-4372-88E0-8DDEEC481822 Q38850831-5F5ACF57-3B9D-4B01-B290-05087D0A45FA Q38962770-551DFBBF-4EEA-4EE1-85EE-C6856C3F646F Q39021948-1FF52480-80C6-41B0-8B1F-A1167CD56614 Q40053203-D50A3DF1-24ED-4BFB-B15B-283D9392ABBB Q45325266-6CF63066-E3EF-4247-9B7F-E05036645329 Q47571734-E6B6E18A-F318-4079-A538-45B60E9966AA Q49202700-4FA01C2D-4251-45B2-9135-C5BA9EBA5B11 Q55003883-9CF2E8D9-C8CB-454F-A876-4FB2D653C047

P2860

Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.

http://www.wikidata.org/entity/Q37562093

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic evaluation of Epst ...... of nasopharyngeal carcinomas.

@en

Therapeutic evaluation of Epst ...... of nasopharyngeal carcinomas.

@nl

type

label

Therapeutic evaluation of Epst ...... of nasopharyngeal carcinomas.

@en

Therapeutic evaluation of Epst ...... of nasopharyngeal carcinomas.

@nl

prefLabel

Therapeutic evaluation of Epst ...... of nasopharyngeal carcinomas.

@en

Therapeutic evaluation of Epst ...... of nasopharyngeal carcinomas.

@nl

P1433

Q37562093-343EF233-729F-45CB-89E4-F58F9E5047C5

P1476

Q37562093-22AB4845-B71D-4EB5-82E4-E7972EA38CB0

P2093

Q37562093-0157BB77-0060-4FA3-AB8E-A918FA2FAB58

Q37562093-0703F6F7-1602-4227-90A0-3DCF917F32C1

Q37562093-0B249496-6BF9-4EA4-BD2D-7A2E44F1B212

Q37562093-28D37148-26DA-4399-A492-69C6C1980439

Q37562093-2D129062-B827-4012-8A62-EC7DFE8BBE18

Q37562093-43DF3F0A-A7E9-404E-A0CD-443735A4FF51

Q37562093-58D88D46-514B-47DD-B3A3-85E306F9D44F

Q37562093-8C432FE2-4A94-455F-B9E7-1E20A4F263D5

Q37562093-8C7DFEA8-9BC0-4F3A-8439-620C3B76CE4E

Q37562093-947094A9-7AAA-4FA7-BDD9-164F243527E2

P2860

Q37562093-048100B4-5FC5-4422-B8E2-78DFCF821808

Q37562093-062E2382-3C7E-4501-8F47-6695F7CF0B40

Q37562093-0769E2B3-1106-4322-A524-60B36B61952E

Q37562093-0C6DC68B-2954-40EB-A7AC-935DE38B3A21

Q37562093-133CA98E-DA0B-4AEB-8C2C-8FD662906F34

Q37562093-1592007E-46B2-4833-A18B-75C637127AEA

Q37562093-223730D3-B64D-492F-A131-7378837DB61C

Q37562093-3632CB46-F6BE-435F-ABAC-495470DCDC1D

Q37562093-3CAD6486-9DC6-434B-93EF-6CD1599084F8

Q37562093-40616820-9CBC-46D1-A855-83D81A6EF09F

P304

Q37562093-12D5132D-0E79-4BB6-87F6-564525FBBE22

P31

Q37562093-A0BA5E8D-3BFE-40E4-9E46-6E01696ED3DE

P356

Q37562093-EBACC15C-F384-4DA1-91CB-9B8571E201EB

P433

Q37562093-FF6AE434-3F2F-4EB8-8186-1CDF752727F2

P478

Q37562093-0217065A-EA4A-4631-9293-A63E74866150

P577

Q37562093-661AAE78-4DFD-498A-949A-457189A0501F

P5875

Q37562093-7CD0038F-954F-475D-8ABE-99B7B3A21BDA

P698

Q37562093-E3ED5C51-F64A-4A4F-A2FE-E006CB41D415

P921

Q37562093-FCE54384-8CEE-44AA-BA48-3650954D1972

P932

Q37562093-6AFA7572-3023-40AE-9BEE-60824E6A48CD

P356

P1433

Molecular Therapy

P1476

Therapeutic evaluation of Epst ...... of nasopharyngeal carcinomas.

@en

P2093

Bob L Hou

http://www.w3.org/2001/XMLSchema#string

Deyun Feng

http://www.w3.org/2001/XMLSchema#string

Faqing Tang

http://www.w3.org/2001/XMLSchema#string

Fengjiao He

http://www.w3.org/2001/XMLSchema#string

Guolin Tan

http://www.w3.org/2001/XMLSchema#string

Jia Fu

http://www.w3.org/2001/XMLSchema#string

Lifang Yang

http://www.w3.org/2001/XMLSchema#string

Ling Zhang

http://www.w3.org/2001/XMLSchema#string

Lun-Quan Sun

http://www.w3.org/2001/XMLSchema#string

Tubao Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Cancer regression in patients after transfer of genetically engineered lymphocytes

A general purpose RNA-cleaving DNA enzyme

Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents

Epstein-Barr virus: 40 years on

EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis.

Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression.

P304

371-377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2013.257

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259252291

http://www.w3.org/2001/XMLSchema#string

P698

24322331

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

3916047

http://www.w3.org/2001/XMLSchema#string